Actively Recruiting
Efficacy of an Assisted Therapy Optimizing Module to Improve Physician Adherence
Led by Medical University Innsbruck · Updated on 2025-02-19
234
Participants Needed
2
Research Sites
147 weeks
Total Duration
On this page
Sponsors
M
Medical University Innsbruck
Lead Sponsor
A
AIT Austrian Institute of Technology GmbH
Collaborating Sponsor
AI-Summary
What this Trial Is About
Heart failure patients within the HM programme
CONDITIONS
Official Title
Efficacy of an Assisted Therapy Optimizing Module to Improve Physician Adherence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written, signed and dated informed consent for inclusion in the HM programme
- Male and female patients over 18 years of age
- Hospitalised for decompensated heart failure requiring intravenous diuretics
- Need for intravenous diuresis outside hospital due to impending cardiac decompensation
You will not qualify if you...
- Multimorbidity with Charlson Comorbidity Index greater than 6
- Diagnosis of dementia
- Lack of willingness to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Medical University of Graz, University Hospital for Internal Medicine (Cardiology)
Graz, Styria, Austria, 8036
Actively Recruiting
2
Medical University of Innsbruck, University Hospital for Internal Medicine III (Cardiology and Angiology)
Innsbruck, Tyrol, Austria, 6020
Actively Recruiting
Research Team
G
Gerhard Poelzl, Prof. Dr.
CONTACT
L
Luca Brunelli, Dr. med.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here